Editas Medicine
NASDAQ: EDIT2 known investors
Editas Medicine develops gene-editing medicines using CRISPR technology to treat serious genetic diseases. The company discovers, develops, and manufactures genomic medicines for patients worldwide.
2 known investors
Editas Medicine develops gene-editing medicines using CRISPR technology to treat serious genetic diseases. The company discovers, develops, and manufactures genomic medicines for patients worldwide.